Harriet S.MeyerMD, Contributing EditorJonathan D.EldredgeMLS, PhD, Journal Review EditorRobertHoganMD, adviser for software
edited by Michael D. Iseman, bimonthly, $140 (physician, microbiologist, researcher), $60 (nurse, retired), $200 (institutional), Paris, France, International Union Against Tuberculosis and Lung Disease, 1997.
The choice of Michael D. Iseman, MD, as editor in chief lends instant credibility to this new journal of tuberculosis and lung disease. The editorial board, moreover, reflects its international scope. Dr Iseman notes in his initial editorial that Robert Koch's announcement in 1890 of a cure and prevention for the disease was as premature as Dr Louis Sullivan's goal almost 100 years later (1989) of eliminating tuberculosis in the United States by the year 2010.
Tuberculosis, in essence, remains a time capsule of infectious disease. Seeds sown during primary infection might stay dormant for decades only to be rejuvenated when the host's immunity declines owing to age, steroids, surgery, malignancy, or HIV infection. Certainly the HIV experience has provided a fertile field for the spread of tuberculosis and, coupled with poor compliance in recalcitrant patients, has led to outbreaks of multidrug-resistant tuberculosis. These conditions justify a new publication focusing on tuberculosis and the worldwide variations in experience.
Tuberculosis and Lung DiseaseThe International Journal of Tuberculosis and Lung Disease. JAMA. 1998;280(13):1200. doi:10.1001/jama.280.13.1200-JBK1007-6-1